Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synbio TechROCO:1295 -1.13%44 Buyback Yield % is -10.76 as of Jul. 26, 2026. GuruFocus rates ROCO:1295 with a GF Score™ of 44/100. The stock has 10 warning signs investors should review. Among 738 Biotechnology companies, Synbio Tech ranks worse than 52.03% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Synbio Tech's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:1295 vs VRTX, REGN, ALNY: Buyback Yield % Comparison
For the Biotechnology subindustry, Synbio Tech's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synbio Tech Buyback Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Synbio Tech's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Synbio Tech's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synbio Tech (ROCO:1295) has a Buyback Yield % of -10.76 as of Jul. 26, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Synbio Tech and its competitors. According to the industry distribution chart, Synbio Tech ranks #384 out of 738 companies in the Biotechnology industry, placing it in the top 52%.
Is Synbio Tech's Buyback Yield % too high?
Synbio Tech's current Buyback Yield % is -10.76. Based on the distribution chart, Synbio Tech ranks #384 out of 738 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Synbio Tech has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Synbio Tech's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Synbio Tech ranks #384 out of 738 companies for Buyback Yield %. This places Synbio Tech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Synbio Tech and its competitors. Synbio Tech's current Buyback Yield % is -10.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synbio Tech stock overvalued right now?
Synbio Tech (ROCO:1295) has a current Buyback Yield % of -10.76. The current Buyback Yield % is -10.76. Synbio Tech's overall GF Score™ is 44/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Synbio Tech (ROCO:1295), the current Buyback Yield % is -10.76 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Synbio Tech Inc focus on functional research and manufacturing of probiotics for human health and economic animals. It has two reportable segments, Taiwan and Mainland China Segment to engage in the production and R&D technologies of the Taiwan Segment, including the production and sales of concentrated fermentation liquid, lactobacillus plantarum solid drinks, and lactobacillus plantarum granules for animal husbandry. It generates majority of revenue from Taiwan segment includes production and sale of lactobacillus plantarum powder, lactobacillus plantarum fermentation derivative products, probiotics dietary supplements, probiotics products for pets and economic animals, and probiotics products. It has presence in Taiwan, China, Southeast Asia, and Others.
44GF Score
Get the complete analysis for ROCO:1295
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1295 has been successfully added to your 
